Genitourinary Cancers Symposium

Healio.com brings you the highlights from the Genitourinary Cancers Symposium. Refer back to this page often to read the latest news from ASCO GU, see perspectives and interviews with leading researchers and clinicians, and review archives of past meetings.

Meeting NewsPerspective

Pembrolizumab plus olaparib safe, active in docetaxel-pretreated men with prostate cancer

February 28, 2019
SAN FRANCISCO — The combination of pembrolizumab and olaparib demonstrated activity in men with metastatic castration-resistant prostate cancer…
Meeting News

Nivolumab, ipilimumab combination shows durable benefit for advanced kidney cancer

February 21, 2019
SAN FRANCISCO — The OS and objective response rate benefits of nivolumab and ipilimumab compared with sunitinib persisted long-term among…
Meeting News

Atezolizumab plus bevacizumab safe, active in non-clear cell, sarcomatoid kidney cancer

February 21, 2019
SAN FRANCISCO — The combination of atezolizumab and bevacizumab demonstrated antitumor activity and appeared safe in patients with non-clear…
Meeting News

Hormone therapies for prostate cancer benefit black men more than white men

February 20, 2019
SAN FRANCISCO — Chemotherapy-naive black men with metastatic castration-resistant
Meeting News

Cytotoxic chemotherapy for testicular cancer linked to increased body fat

February 20, 2019
SAN FRANCISCO — Young men with metastatic testicular cancer who underwent cytotoxic chemotherapy experienced increases in
Meeting News

First-line avelumab, axitinib benefit persists across advanced kidney cancer patient subgroups

February 19, 2019
SAN FRANCISCO — The combination of avelumab and axitinib induced longer PFS and higher objective response rates than sunitinib among previously…
Meeting News

Adjuvant chemotherapy with radiotherapy improves survival in locally advanced bladder cancer

February 18, 2019
SAN FRANCISCO — Adding adjuvant chemotherapy to postoperative radiotherapy improved DFS and OS among patients with locally advanced bladder…
Meeting News

Early tumor shrinkage associated with OS benefit from cabozantinib in advanced kidney cancer

February 18, 2019
SAN FRANCISCO — Cabozantinib induced early tumor shrinkage — associated with prolonged OS — at a higher rate and to a greater…
Meeting News

Malignant pheochromocytomas harbor a variety of genomic alterations

February 17, 2019
SAN FRANCISCO — Malignant pheochromocytomas appeared to feature a variety of genomic alterations, some of which, including RET, NF1 and…
Meeting News

Retroperitoneal lymph node dissection demonstrates ‘excellent’ survival rates for testicular seminoma

February 16, 2019
SAN FRANCISCO — Retroperitoneal lymph node dissection conferred favorable survival rates among men with testicular seminoma used as first-line…